About this document
Nanomedicine in Antidiabetic Drug Delivery by publication1 is a document available to read on EtoBox.
The document discusses the role of nanomedicine in the targeted delivery of antidiabetic drugs, highlighting its potential to improve drug bioavailability, stability, and therapeutic efficacy. It reviews various nanocarriers, such as polymeric nanoparticles, liposomes, and dendrimers, and their applications in insulin and oral hypoglycemic agent delivery. The review emphasizes the need for further research on safety and regulatory challenges to fully integrate nanomedicine into diabetes management.
- Author
- publication1
- Language
- EN